Patient with NSTE-ACS, 70 yrs, no AF, planned PCI, low bleeding risk: what strategy would you choose?
#NSTEMIRoundtable2021
Radcliffe Cardiology
25.2K posts
Radcliffe Cardiology
@radcliffeCARDIO
Radcliffe Cardiology is a dynamic, digitally-focused producer & publisher of Cardiovascular, Renal and Metabolic (CVRM) content for physicians worldwide.
Joined May 2009
- Which statement best describes your attitude towards pre-treatment of NSTE-ACS, with a #P2Y12 inhibitor? #NSTEMIRoundtable2021
- Post-PCI, which stent optimisation feature are you least confident assessing? Learn more 👉 bit.ly/3ryWKyd
- Which of the following presents the biggest challenge for your procedure planning, pre-PCI? Learn more 👉 bit.ly/3wPBzsn
- What is the biggest barrier to adopting SGLT-2 inhibitors in your clinical practice? #heartfailure #esc2021 #ECSCongress @BiykemB @lamcardio
- Which approach do you most frequently use to guide DES implantation? Learn More 👉🏻 bit.ly/3w0ZO74
- How could AHA clinical trials impact current ESC guideline recommendations? #AHA21 👉USE #AHARME TO JOIN THE CONVERSATION 👈 Learn more about Heart Failure - bit.ly/3mKjKcA ❌Not intended for US HCPs @GiuseppeGalati_ @ShelleyZieroth @ValleAlfonso @hvanspall
- What is the future importance of #EjectionFraction for therapy selection in #HeartFailure? Share your thoughts below! Click the link to join the discussion on latest #HF guidelines with @BiykemB @NMHheartdoc @ilppina & Dr Andrew Coats. 👇 bit.ly/3E23kCM
- Thank you for joining #PCRRME at #PCRLV. Check out our educational videos on REPAIR or REPLACE and REAL-WORLD data with @PhilippLurz @masitges @m_taramasso Access the videos here 👉 bit.ly/3EVItCE #cardiotwitter #LondonValves #cardioed #TMVR #TEER
- Will transcatheter tricuspid valve repair become a first line option in severe tricuspid regurgitation over surgery? 👉USE #PCRRME TO JOIN👈 @PhilippLurz @masitges @m_taramasso #cardiotwitter #LondonValves #cardioed #TMVR #TEE
- Follow and join the conversation at #AHA21 with leading #HF specialists @GiuseppeGalati_ @ShelleyZieroth @ValleAlfonso @hvanspall 👉USE #AHARME TO JOIN👈 Learn more about Heart Failure - ow.ly/E44F50GJ3Fs ❌Not intended for US HCPs #cardiotwitter #cardiology
00:00 - 49 yr female; #CKD (no T2DM); eGFR 30; on ARB. What do you treat with to prevent further decline? Join the conversation: bit.ly/3H9PLSZ #CardioTwitter #MedEd #Epeeps @kamleshkhunti @HeerspinkHiddo @ShelleyZieroth
- Valve repair or replacement: Does real-world evidence influence your treatment choice? 👉USE #PCRRME TO JOIN👈 @PhilippLurz @masitges @m_taramasso #cardiotwitter #LondonValves #cardioed #TMVR #PCRLV